Journal of Medical Physics
 Home | Search | Ahead of print | Current Issue | Archives | Instructions | Subscription | Login  The official journal of AMPI, IOMP and AFOMP      
 Users online: 1470  Home  EMail this page Print this page Decrease font size Default font size Increase font size 
Year : 2019  |  Volume : 44  |  Issue : 4  |  Page : 276-282

The impact of positron emission tomography/computed tomography addition to contrast-enhanced computed tomography findings during radiation treatment planning of locally advanced carcinoma esophagus

1 Department of Radiation Oncology, Army Hospital Research & Referral, New Delhi, India
2 Department of Radiation Oncology, Narayana Superficiality Hospitals, Kolkata, West Bengal, India
3 Department of Radiation Oncology, Command Hospital (Central Command), Lucknow, Uttar Pradesh, India

Correspondence Address:
Dr. Shweta Sharma
House No 7/83, VI Floor, Turf View, Defence Officer's Enclave, AJC Bose Marg, Near Alipore Zoo, Alipore, Kolkata - 700 022, West Bengal
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jmp.JMP_13_19

Rights and Permissions

Introduction: Does metabolic imaging help in better definition of target during radiation treatment planning by bringing about changes in dimensions of the primary tumor in terms of diameter, length, and picking up new skip lesions or nodal stations which in turn prevents geographic misses by including more 18F-fluorodeoxyglucose avid regions not visible on conventional imaging? Materials and Methods: We compared the length and radial dimensions of the primary tumor as well as changes brought about due to addition of new nodal stations, involved structures, and skip lesions in 50 patients of carcinoma esophagus treated between 2011 and 2013, as seen on contrast-enhanced computed tomography (CT) thorax and positron emission tomography (PET)/CT and drew conclusions regarding the technical changes brought about in treatment planning by the additional input of PET/CT. Results and Conclusions: PET-CT tremendously changes treatment plans by expanding the gross tumor volume and including regions which might otherwise have been missed on purely CT-based plans. Of the 50 patients, it changed the contouring and treatment planning of 35 patients and did not impact the remaining 15. Whether this translates into better long-term controls requires further validation by randomized controlled trials, which was not our present objective.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded158    
    Comments [Add]    

Recommend this journal